Monash Centre for Health Research and Implementation, Monash University, Clayton, Victoria, Australia
Australian Institute for Musculoskeletal Science, Victoria University, Melbourne, Victoria, Australia
Medicine-Western Health, Faculty of Medicine, Dentistry and Health Science, Melbourne University, Melbourne, Victoria, Australia
Search for other papers by N K Stepto in
Google Scholar
PubMed
Search for other papers by D Hiam in
Google Scholar
PubMed
Search for other papers by M Gibson-Helm in
Google Scholar
PubMed
Search for other papers by S Cassar in
Google Scholar
PubMed
Search for other papers by C L Harrison in
Google Scholar
PubMed
Search for other papers by S K Hutchison in
Google Scholar
PubMed
Search for other papers by A E Joham in
Google Scholar
PubMed
Search for other papers by B J Canny in
Google Scholar
PubMed
Australian Institute for Musculoskeletal Science, Victoria University, Melbourne, Victoria, Australia
Search for other papers by A Moreno-Asso in
Google Scholar
PubMed
Division of Diabetes, Endocrinology & Gastroenterology, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK
Search for other papers by B J Strauss in
Google Scholar
PubMed
Search for other papers by N Hatzirodos in
Google Scholar
PubMed
Search for other papers by R J Rodgers in
Google Scholar
PubMed
Diabetes and Endocrine Units, Monash Health, Clayton, Victoria, Australia
Search for other papers by H J Teede in
Google Scholar
PubMed
, (B) COL3A1 , (C) DCN , (D) IGF1 , (E) LOX , (F) SMAD2 , (G) TGF1I1 , (H) LTBP1 , (I) TGFB1 , (J) TGFB2 , (K) TGFB3 , (L) TGFBR2 . These data are from a subset of women ( n = 59) ( 9 ). Covariate adjusted statistical difference reported: a
Search for other papers by María L Bacigalupo in
Google Scholar
PubMed
Search for other papers by Verónica G Piazza in
Google Scholar
PubMed
Search for other papers by Nadia S Cicconi in
Google Scholar
PubMed
Search for other papers by Pablo Carabias in
Google Scholar
PubMed
Search for other papers by Andrzej Bartke in
Google Scholar
PubMed
Search for other papers by Yimin Fang in
Google Scholar
PubMed
Search for other papers by Ana I Sotelo in
Google Scholar
PubMed
Search for other papers by Gabriel A Rabinovich in
Google Scholar
PubMed
Search for other papers by María F Troncoso in
Google Scholar
PubMed
Search for other papers by Johanna G Miquet in
Google Scholar
PubMed
://doi.org/10.1530/EC-18-0099 ) 5 Guevara-Aguirre J Guevara A Palacios I Pérez M Prócel P Terán E . GH and GHR signaling in human disease . Growth Hormone and IGF Research 2018 38 . ( https://doi.org/10.1016/j.ghir.2017.12.006 ) 6 Jenkins
Search for other papers by Jose M Garcia in
Google Scholar
PubMed
Search for other papers by Beverly M K Biller in
Google Scholar
PubMed
Search for other papers by Márta Korbonits in
Google Scholar
PubMed
Search for other papers by Vera Popovic in
Google Scholar
PubMed
Search for other papers by Anton Luger in
Google Scholar
PubMed
Search for other papers by Christian J Strasburger in
Google Scholar
PubMed
Search for other papers by Philippe Chanson in
Google Scholar
PubMed
Search for other papers by Ronald Swerdloff in
Google Scholar
PubMed
Search for other papers by Christina Wang in
Google Scholar
PubMed
Search for other papers by Rosa Rosanna Fleming in
Google Scholar
PubMed
Search for other papers by Fredric Cohen in
Google Scholar
PubMed
Search for other papers by Nicola Ammer in
Google Scholar
PubMed
Search for other papers by Gilbert Mueller in
Google Scholar
PubMed
Search for other papers by Nicky Kelepouris in
Google Scholar
PubMed
Search for other papers by Frank Strobl in
Google Scholar
PubMed
Search for other papers by Vlady Ostrow in
Google Scholar
PubMed
Search for other papers by Kevin C J Yuen in
Google Scholar
PubMed
on diagnosis and disease progression ( 17 ). Thus, except in patients with panhypopituitarism and low insulin-like growth factor I (IGF-I) levels, the diagnosis of AGHD often requires confirmation using a provocative GH stimulation test (GHST) ( 18
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
School of Nursing and Midwifery, Institute of Clinical Sciences, University of Birmingham, UK
Search for other papers by Sherwin Criseno in
Google Scholar
PubMed
Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Search for other papers by Helena Gleeson in
Google Scholar
PubMed
Search for other papers by Andrew A Toogood in
Google Scholar
PubMed
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Search for other papers by Neil Gittoes in
Google Scholar
PubMed
Search for other papers by Anne Topping in
Google Scholar
PubMed
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Search for other papers by Niki Karavitaki in
Google Scholar
PubMed
and Metabolism 2003 88 1658 – 1663 . ( https://doi.org/10.1210/jc.2002-021541 ) 21 Attanasio AF Howell S Bates PC Frewer P Chipman J Blum WF & Shalet SM . Body composition, IGF-I and IGFBP-3 concentrations as outcome measures in
Department of Pediatric Endocrinology, Wilhelmina Children’s Hospital, University Medical Center, Lundlaan, EA Utrecht, The Netherlands
Search for other papers by I M A A van Roessel in
Google Scholar
PubMed
Department of Pediatric Endocrinology, Wilhelmina Children’s Hospital, University Medical Center, Lundlaan, EA Utrecht, The Netherlands
Search for other papers by J E Gorter in
Google Scholar
PubMed
Department of Pediatric Endocrinology, Wilhelmina Children’s Hospital, University Medical Center, Lundlaan, EA Utrecht, The Netherlands
Search for other papers by B Bakker in
Google Scholar
PubMed
Wilhelmina Children’s Hospital, University Medical Center, Lundlaan, EA Utrecht, The Netherlands
Search for other papers by M M van den Heuvel-Eibrink in
Google Scholar
PubMed
Department of Radiology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands
Search for other papers by M H Lequin in
Google Scholar
PubMed
Search for other papers by J van der Lugt in
Google Scholar
PubMed
Search for other papers by L Meijer in
Google Scholar
PubMed
Search for other papers by A Y N Schouten-van Meeteren in
Google Scholar
PubMed
Department of Pediatric Endocrinology, Wilhelmina Children’s Hospital, University Medical Center, Lundlaan, EA Utrecht, The Netherlands
Search for other papers by H M van Santen in
Google Scholar
PubMed
following situations: vertebral fractures grade I-III according to the Genant semiquantitative method (on MRI scan or x-ray of the spine) ( 9 , 24 ), ‘very low BMD’ on a DXA scan ( 21 ), or ‘very low BMD’ as determined by BHI ( 22 ). The presence of a bone
Search for other papers by Mei Li in
Google Scholar
PubMed
Search for other papers by Yanfei Chen in
Google Scholar
PubMed
Search for other papers by Binrong Liao in
Google Scholar
PubMed
Search for other papers by Jing Tang in
Google Scholar
PubMed
Search for other papers by Jingzi Zhong in
Google Scholar
PubMed
Search for other papers by Dan Lan in
Google Scholar
PubMed
-2000i, Shenzhen, China), with intra- and inter-assay CVs of LH, FSH, and E2 less than 10%. Insulin-like growth factor-1 (IGF-1) was tested by chemiluminescence (BIOBASE, MAGLUMI 4000 plus, Shandong, China). The serum MKRN3 and kisspeptin levels were
Search for other papers by Antonia Ertelt in
Google Scholar
PubMed
Search for other papers by Ann-Kristin Barton in
Google Scholar
PubMed
Search for other papers by Robert R Schmitz in
Google Scholar
PubMed
Search for other papers by Heidrun Gehlen in
Google Scholar
PubMed
-like growth factor-1 receptor in the pathogenesis of hyperinsulinaemic laminitis . Veterinary Journal 2013 197 302 – 306 . ( doi:10.1016/j.tvjl.2012.12.026 ). 127 Laviola L Natalicchio A Giorgino F . The IGF-I signaling pathway . Current
Search for other papers by Jakub Supronik in
Google Scholar
PubMed
Search for other papers by Małgorzata Szelachowska in
Google Scholar
PubMed
Clinical Research Centre, Medical University of Bialystok, Bialystok, Poland
Search for other papers by Adam Kretowski in
Google Scholar
PubMed
Search for other papers by Katarzyna Siewko in
Google Scholar
PubMed
CXCL10 and that decrease was linked with a reduction of TRAb titers ( 13 , 15 ). Current management For a very long time, the mainstay of GO treatment has been the administration of i.v. glucocorticosteroids (ivGCS), which was frequently
Search for other papers by Nancy Martini in
Google Scholar
PubMed
Search for other papers by Lucas Streckwall in
Google Scholar
PubMed
Search for other papers by Antonio Desmond McCarthy in
Google Scholar
PubMed
turn, depends on the balance between (i) procalcifying factors, such as type 2 bone morphogenic protein (BMP2), RANKL, hyperphosphataemia, hypercalcaemia, oxidative stress, subendothelial accumulation of advanced glycation end-products (AGEs), oestrogen
Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
Search for other papers by Andre Madsen in
Google Scholar
PubMed
International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Anders Juul in
Google Scholar
PubMed
International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
Search for other papers by Lise Aksglaede in
Google Scholar
PubMed
Endocrinology and Metabolism 1998 271 – 276 . ( https://doi.org/10.1016/s1043-2760(9800069-132 ) 32 Aksglaede L Skakkebaek NE & Juul A . Abnormal sex chromosome constitution and longitudinal growth: serum levels of insulin-like growth factor (IGF)-I